- Home
- ATER vs GDTC Comparison
ATER vs GDTC Comparison
Compare ATER & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATER
- GDTC
- Stock Information
- Founded
- ATER 2014
- GDTC 2018
- Country
- ATER United States
- GDTC Singapore
- Employees
- ATER N/A
- GDTC N/A
- Industry
- ATER Home Furnishings
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- ATER Consumer Discretionary
- GDTC Health Care
- Exchange
- ATER Nasdaq
- GDTC Nasdaq
- Market Cap
- ATER 25.8M
- GDTC 25.1M
- IPO Year
- ATER N/A
- GDTC 2023
- Fundamental
- Price
- ATER $2.54
- GDTC $2.17
- Analyst Decision
- ATER Strong Buy
- GDTC Buy
- Analyst Count
- ATER 1
- GDTC 1
- Target Price
- ATER N/A
- GDTC $5.00
- AVG Volume (30 Days)
- ATER 47.4K
- GDTC 22.4K
- Earning Date
- ATER 11-11-2024
- GDTC 01-01-0001
- Dividend Yield
- ATER N/A
- GDTC N/A
- EPS Growth
- ATER N/A
- GDTC N/A
- EPS
- ATER N/A
- GDTC N/A
- Revenue
- ATER $107,193,000.00
- GDTC $330,254.00
- Revenue This Year
- ATER N/A
- GDTC $14.71
- Revenue Next Year
- ATER $5.45
- GDTC N/A
- P/E Ratio
- ATER N/A
- GDTC N/A
- Revenue Growth
- ATER N/A
- GDTC N/A
- 52 Week Low
- ATER $0.23
- GDTC $1.20
- 52 Week High
- ATER $3.95
- GDTC $5.50
- Technical
- Relative Strength Index (RSI)
- ATER 32.74
- GDTC 47.02
- Support Level
- ATER $2.85
- GDTC $2.11
- Resistance Level
- ATER $3.10
- GDTC $2.60
- Average True Range (ATR)
- ATER 0.19
- GDTC 0.33
- MACD
- ATER -0.02
- GDTC -0.07
- Stochastic Oscillator
- ATER 0.35
- GDTC 34.42
About ATER Aterian Inc.
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operated brands including Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.